CLASS II ONGOING Device recall · Reported 26 Aug 2020 · FDA Enforcement Report

Alaris SpO2 Module recalled by CareFusion 303

CareFusion 303 is recalling Alaris SpO2 Module, distributed nationwide in the US. The recall was initiated on 30 Jun 2020 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesAll serial numbers
Quantity recalled8558

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-2826-2020
FDA event ID
85919
Recalling firm
CareFusion 303, San Diego, CA
Classification
Class II
Status
Ongoing
Recall initiated
30 Jun 2020
FDA classified
19 Aug 2020
Reported
26 Aug 2020
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Other Reasons

Timeline

30 Jun 2020Recall initiated by company
19 Aug 2020Classified by FDA+50 days
26 Aug 2020Published in enforcement report+7 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

LED display, which provides infusion or patient monitoring values, on the module may have segments that appear dim.

Product as listed by the FDA

Alaris SpO2 Module Model 8210 and Model 8220 - Product Usage: is intended to provide trained healthcare caregivers a way to automate the programming of infusion parameters, thereby decreasing the amount of manual steps necessary to enter infusion data.

Where it was distributed

Worldwide distribution - U.S. Nationwide distribution including in the states of CO, FL, SC, NY, CA, NC, TX, IL, PA, AZ, LA, IN, MA, MO, AR, WI, HI, OR, OH, NJ, TN, NE, WA, KS, MI, MD, WV, KY, UT, MN, IA, GA, AL, DE, AK, VA, OK, NM, CT, SD, NV, ID, MT, ME, VT, MS, WY, NH, MP, DC, ND, GU, PR, AS, RI and the countries of TR, QA, CA, AE, KW, MX, GI, IL, SA, CH, NL, BE, TW, ZA, PH, CN, AU, IN, FR, MY, NZ, GB, KR, PK, DE, SG, JP, CU, IT, BH.

Nationwide AlaskaAlabamaArkansasArizonaCaliforniaColoradoConnecticutDistrict of ColumbiaDelawareFloridaGeorgiaHawaiiIowaIdahoIllinoisIndianaKansasKentuckyLouisianaMassachusetts

Questions about this recall

Is Alaris SpO2 Module recalled?

Yes. CareFusion 303 recalled Alaris SpO2 Module on 30 Jun 2020. The recall is Class II and its status is Ongoing. Recall number Z-2826-2020.

Why was it recalled?

LED display, which provides infusion or patient monitoring values, on the module may have segments that appear dim.

Which lots are affected?

All serial numbers

Where was it sold?

Worldwide distribution - U.S. Nationwide distribution including in the states of CO, FL, SC, NY, CA, NC, TX, IL, PA, AZ, LA, IN, MA, MO, AR, WI, HI, OR, OH, NJ, TN, NE, WA, KS, MI, MD, WV, KY, UT, MN, IA, GA, AL, DE, AK, VA, OK, NM, CT, SD, NV, ID, MT, ME, VT, MS, WY, NH, MP, DC, ND, GU, PR, AS, RI and the countries of TR, QA, CA, AE, KW, MX, GI, IL, SA, CH, NL, BE, TW, ZA, PH, CN, AU, IN, FR, MY, NZ, GB, KR, PK, DE, SG, JP, CU, IT, BH.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from CareFusion 303

All 143

Other Other Medical Devices recalls

All 13,778